📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Acceleron Pharma

1.1 - Company Overview

Acceleron Pharma Logo

Acceleron Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases; engaged in developing, manufacturing, and commercializing these products, including the ACE-011 program, a novel bone-forming program.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Acceleron Pharma

Glycotope Logo

Glycotope

HQ: Germany Website
  • Description: Provider of GMP-compliant contract manufacturing for active biopharmaceutical ingredients (proteins and antibodies) via recombinant production, and oncology antibody solutions including GT-001 (Lewis Y), GT-002 (LYPD3), GT-00A (MUC1) and an IL-15 immuno-cytokine, plus GlycoTarget Discovery and a platform enabling high tumor-specificity by targeting tumor-associated carbohydrates for ADC/CAR development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Glycotope company profile →
Alltrna Logo

Alltrna

HQ: United States Website
  • Description: Provider of a tRNA therapeutics platform that uses machine learning and high-throughput proprietary in vitro assays to design and optimize therapeutic tRNA molecules for diseases with genetic mutations. Solutions include tRNA medicines that read stop codons to restore full-length protein production, with data-integrated workflows to refine predictive design.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alltrna company profile →
CoGenesys Logo

CoGenesys

HQ: United States Website
  • Description: Provider of peptide- and protein-based medicine development for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CoGenesys company profile →
ARMO BioSciences Logo

ARMO BioSciences

HQ: United States Website
  • Description: Provider of immune modulatory biologic therapeutics, from a biotechnology company based in Redwood City, California.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ARMO BioSciences company profile →
Fortress Biotech Logo

Fortress Biotech

HQ: United States Website
  • Description: Provider of biopharmaceutical therapies, focused on acquiring, developing and commercializing therapeutic products. Pipeline: Cosibelimab (fully human PD-L1 antibody) for EGFR mutation–positive non-small cell lung cancer; DFD-29 for inflammatory lesions of rosacea; IV Tramadol for post-surgical pain; AJ201 for spinal and bulbar muscular atrophy; BAER-101 for CNS disorders.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Fortress Biotech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Acceleron Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Acceleron Pharma

2.2 - Growth funds investing in similar companies to Acceleron Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Acceleron Pharma

4.2 - Public trading comparable groups for Acceleron Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Acceleron Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Acceleron Pharma

What does Acceleron Pharma do?

Acceleron Pharma is a provider of novel biotherapeutics that modulate the growth of bone, muscle, fat, and the vasculature to treat musculoskeletal, metabolic, and cancer-related diseases; engaged in developing, manufacturing, and commercializing these products, including the ACE-011 program, a novel bone-forming program.

Who are Acceleron Pharma's competitors?

Acceleron Pharma's competitors and similar companies include Glycotope, Alltrna, CoGenesys, ARMO BioSciences, and Fortress Biotech.

Where is Acceleron Pharma headquartered?

Acceleron Pharma is headquartered in United States.

How many employees does Acceleron Pharma have?

Acceleron Pharma has 1,000 employees 🔒.

When was Acceleron Pharma founded?

Acceleron Pharma was founded in 2010 🔒.

What sector and industry vertical is Acceleron Pharma in?

Acceleron Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Acceleron Pharma

Who are the top strategic acquirers in Acceleron Pharma's sector and industry

Top strategic M&A buyers and acquirers in Acceleron Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Acceleron Pharma?

Top strategic M&A buyers groups and sectors for Acceleron Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Acceleron Pharma's sector and industry vertical

Which are the top PE firms investing in Acceleron Pharma's sector and industry vertical?

Top PE firms investing in Acceleron Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Acceleron Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Acceleron Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Acceleron Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Acceleron Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Acceleron Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Acceleron Pharma?

The key public trading comparables and valuation benchmarks for Acceleron Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Acceleron Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Acceleron Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Acceleron Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Acceleron Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Acceleron Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Acceleron Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Acceleron Pharma